Open Society invests $6 million for global access to biologics

Awarded through the Soros Economic Development Fund, the investment in Univercells, a Belgian biotech company, will support efforts to remove manufacturing bottlenecks in the production of COVID-19 vaccines and help develop distributed manufacturing capacity in middle-income countries globally….

Philanthropy News Digest | https://philanthropynewsdigest.org/rss/feed/pndnews

Goto full post >>